Search
Henatinib
go.drugbank.com/drugs/DB13019InvestigationalHenatinib has been used in trials studying the treatment of Advanced Solid Cancer.
IPI-493
go.drugbank.com/drugs/DB13023InvestigationalIPI-493 has been used in trials studying the treatment of Advanced Malignancies.
CEP-37440
go.drugbank.com/drugs/DB13060InvestigationalCEP-37440 has been used in trials studying the treatment of Solid Tumors.
LY-2811376
go.drugbank.com/drugs/DB13065InvestigationalLY2811376 has been used in trials studying the basic science of Alzheimer's Disease.
AZD-0424
go.drugbank.com/drugs/DB13088InvestigationalAZD0424 has been used in trials studying the treatment of Advanced Solid Tumours.
TAK-593
go.drugbank.com/drugs/DB13093InvestigationalTAK-593 has been used in trials studying the treatment of Solid Tumors.
Macozinone
go.drugbank.com/drugs/DB14821InvestigationalMacozinone is under investigation in clinical trial NCT03036163 (Phase 1 Study of PBTZ169).
JQ1
go.drugbank.com/drugs/DB17021ExperimentalFirst-in-class potent and selective inhibitor of the BRD4 signaling pathway.[A252967]
NKX101
go.drugbank.com/drugs/DB18131InvestigationalNKX101 is an investigational allogeneic chimeric antigen receptor (CAR)-natural killer cell therapy.
Synonyms: a fourth generation activating chimeric receptor (ACR) natural killer (NK) cell therapy engineered with an NKG2D ACR, OX40 costimulatory domain, CD3zeta signaling moiety, and membrane bound IL-15 (mb-IL15Limonene, (+/-)-
go.drugbank.com/drugs/DB19146InvestigationalLimonene, (+/-)- is under investigation in clinical trial NCT05525260 (Limonene for Pulmonary Nodule Chemoprevention).